AV

Abishek Venkatasubramanian Iyer

Active Director Director DIN 10592894
DIN 10592894 First appointment Apr 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Abishek Venkatasubramanian Iyer

Data last updated:

Abishek Venkatasubramanian Iyer is a Director at Ashta Therapeutics Private Limited (since 2024). The company operates in Paper.

DIN 10592894
Primary Designation Director
Industry Paper
First Appointment 16 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ashta Therapeutics Private Limited U21001GJ2024PTC150672
Director16 Apr 20242024Active

Board colleagues of Abishek Venkatasubramanian Iyer

Directorship timeline

Open interactive timeline →
Ashta Therapeutics Private Limited
Premium access

Shareholding and investment profile for Abishek Venkatasubramanian Iyer

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abishek Venkatasubramanian Iyer

Abishek Venkatasubramanian Iyer currently holds 1 directorship: Ashta Therapeutics Private Limited (Director, since 16 Apr 2024).

Abishek Venkatasubramanian Iyer was first appointed on 16 Apr 2024 as Director at Ashta Therapeutics Private Limited.

The current boards of Abishek Venkatasubramanian Iyer's companies include Jankiben Kunalbhai Brahmbhatt (Ashta Therapeutics Private Limited), Jesal Niranjan Shah (Ashta Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available